RT Journal Article
SR Electronic
T1 Attitudes of the US general public towards Monkeypox
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.20.22276527
DO 10.1101/2022.06.20.22276527
A1 Malik, Amyn A.
A1 Winters, Maike S.
A1 Omer, Saad B.
YR 2022
UL http://medrxiv.org/content/early/2022/06/21/2022.06.20.22276527.abstract
AB While the Monkeypox outbreak is growing, little is known about the general public’s levels of knowledge, their trusted sources of information and attitudes towards a Monkeypox vaccine. In our representative survey of the US general public, we find that almost half the respondents (47%) feel that their knowledge level about Monkeypox is poor or very poor. The most trusted sources of information about the outbreak are healthcare professional and officials, but also known doctors and researchers with a large online following. Being vaccinated against COVID-19 was a strong predictor of willingness to receive a Monkeypox if recommended (adjusted Odds Ratio 32.1, 95% Confidence Interval 16.7-61.7). Our findings point to the urgent need for clear communication.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of Yale University gave ethical approval for this study (IRB protocol number 2000032980)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors